Bayer funds educational programs to improve early diagnosis, screening, and management of chronic kidney disease in type 2 diabetes, focusing on guideline-based practices and cardio-renal risk reduction.
This Bayer grant funds clinician education projects on Cardio-Kidney-Metabolic syndrome, risk prediction, and evidence-based therapies using diverse educational formats.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
The PKD Foundation Research Grants fund innovative research into the biology, mechanisms, and treatment of polycystic kidney disease across basic to clinical science.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants support researchers studying druggable targets and biomarkers to advance new kidney cancer treatments, diagnosis, monitoring, and prognosis.